InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Parlati Francesco, Directeur. Director active across 1 company, notably Calithera Biosciences, Inc.. Cumulatively, 8 filings have been published. Activity tracked since 27 October 2021. The latest transaction was disclosed on 21 January 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations8 total
4,794 shares@ US$0.491585.49% mcap8.2% of flowCommon StockSEC:0000899243-22-003139:0
4,794 shares@ US$0.491585.49% mcap16.5% of flowCommon StockSEC:0000899243-22-003139
18,077 shares@ US$0.660483.5% of flowCommon StockSEC:0000899243-22-001301
18,077 shares@ US$0.660441.8% of flowCommon StockSEC:0000899243-22-001301:0
30,000 shares0Common StockSEC:0000899243-21-043680:0
30,000 shares0Common StockSEC:0000899243-21-043680
90,000 shares0Common StockSEC:0000899243-21-042062:0
90,000 shares0Common StockSEC:0000899243-21-042062
8 of 8 declarations
About Parlati Francesco
Parlati Francesco is SR. VP of research at Calithera Biosciences, Inc., a biopharmaceutical company. He oversees research and development programs, contributing to innovation and advancement in medical treatments.
